Nektar Therapeutics

📍 San Francisco, United States🗓 Founded 1990👥 621 employees💰 Last funded Jun 2025
Biotechnology🌐 nektar.com
Website LinkedIn
Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektars proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
1990
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Brazil
1
Italy
1
Frequently asked questions
Who invested in Nektar Therapeutics?
Nektar Therapeutics has 2 investors on record on gritt.io.
When did Nektar Therapeutics last raise funding?
The most recent investment in Nektar Therapeutics recorded on gritt.io was in June 2025.
When was Nektar Therapeutics founded?
Nektar Therapeutics was founded in 1990.
What industry is Nektar Therapeutics in?
Nektar Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Nektar Therapeutics based?
Nektar Therapeutics is headquartered in San Francisco, United States.